Merck & Co., Inc. (6MK)
XDUS
Real-time Data
06:00 AM
Day's Range
128.4252 wk Range
66.30Overview - 6MK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
34.77B
P/E (Trailing)
‪17.49‬
EV / EBITDA
‪1.19‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪74.80%‬
Operating Margin
‪34.49%‬
Return on Assets
‪13.33%‬
Return on Equity
‪34.66%‬
Ownership
Shares Outstanding
2.46B
Price stats
50-Day Avg
‪89.95‬
200-Day Avg
‪76.25‬
Dividends
Frequency
Quarterly
Peers - 6MK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- 6MKXDUSMerck & Co., Inc.+41.66%52-week change17.34P/E (Trailing)‪74.80%‬Profit Margin
- LLYXDUSEli Lilly and Company+44.43%52-week change46.77P/E (Trailing)‪83.04%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.31%52-week change-12.72P/E (Trailing)‪58.75%‬Profit Margin
- IDPXDUSBiogen Inc.+36.31%52-week change20.87P/E (Trailing)‪75.69%‬Profit Margin
- JNJXDUSJohnson & Johnson+33.91%52-week change20.83P/E (Trailing)‪67.87%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+32.38%52-week change19.41P/E (Trailing)‪67.87%‬Profit Margin
- 7XPXDUSOrganon & Co.+32.30%52-week change16.31P/E (Trailing)‪53.29%‬Profit Margin
Profile Summary - 6MK - Merck & Co., Inc.
About
Merck & Co., Inc. operates as a leading healthcare company worldwide, focusing on human health pharmaceuticals, vaccines, and animal health products. Its portfolio includes blockbuster drugs like Keytruda for immuno-oncology, Gardasil for human papillomavirus prevention, and a range of treatments such as Welireg,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
